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Abstract
Background: Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) are expressed by
microglia and infiltrating macrophages following ischemic stroke. Whereas IL-1β is primarily
neurotoxic in ischemic stroke, TNF-α may have neurotoxic and/or neuroprotective effects. We
investigated whether IL-1β and TNF-α are synthesized by overlapping or segregated populations
of cells after ischemic stroke in mice.
Methods: We used flow cytometry and immunohistochemistry to examine cellular co-expression
of IL-1β and TNF-α at 6, 12 and 24 hours after permanent middle cerebral artery occlusion in mice,
validating the results by the use of bone marrow chimeric mice.
Results: We found that IL-1β and TNF-α were expressed in largely segregated populations of
CD11b+CD45dim  microglia and CD11b+CD45high  macrophages, with cells expressing both
cytokines only rarely. The number of Gr1+ granulocytes producing IL-1β or TNF-α was very low,
and we observed no IL-1β- or TNF-α-expressing T cells or astrocytes.
Conclusion: Taken together, the results show that IL-1β and TNF-α are produced by largely
segregated populations of microglia and macrophages after ischemic stroke in mice. Our findings
provide evidence of a functional diversity among different subsets of microglia and macrophages
that is potentially relevant to future design of anti-inflammatory therapies in stroke.
Background
The proinflammatory cytokines interleukin-1β (IL-1β)
and tumor necrosis factor-α (TNF-α) play key roles in the
pathogenesis of ischemic stroke [1-3]. IL-1β exerts neuro-
toxic effects in ischemic stroke and blocking its action has
been shown to reduce ischemic brain damage [4,5]. In
comparison, there is evidence that TNF-α has both neuro-
toxic [6,7] and neuroprotective [8-10] roles after ischemic
stroke in rats and in mice. Increasing evidence implicates
both cytokines in the early inflammatory response that
precedes and accompanies ischemia-induced neuronal
damage [6,11]. However, detailed knowledge about the
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contribution of different cell types to the production of IL-
1β and TNF-α is still not available.
The relative physiological outcome of increased IL-1β and
TNF-α signaling in ischemic stroke may depend on the
kinetics and location of cytokine producing cells. There is
compelling evidence that IL-1β and TNF-α are primarily
synthesized by activated microglia and infiltrating macro-
phages [12-14], although granulocytes and astrocytes
have also been suggested to produce both IL-1β [15-17]
and TNF-α [18,19]. Precise identification of cell source
has, however, been compromised by the lack of microglial
and macrophage specific markers, which prevents dis-
crimination of these cell types at the histological level
[12,14]. Furthermore, it is presently unknown whether IL-
1β and TNF-α are expressed to the same extent by the
same or different subsets of microglia and macrophages
following ischemic stroke.
We have previously shown that IL-1β mRNA and TNF-α
mRNA, and TNF-α protein are produced by CD11b+
microglia and by CD11b+ macrophages at the edge of and
within areas of infarction, and that this production
reaches maximum levels of expression between 12 and 24
hours after permanent middle cerebral artery occlusion
(pMCAO) in mice [12,14,20]. The objective of the present
study was to provide additional insight into the cell types
and cell subpopulations that produce IL-1β and TNF-α
within the first 24 hours following ischemic stroke in mice
[20]. To distinguish microglia from infiltrating macro-
phages after pMCAO, we used flow cytometry with CD45
and CD11b as myeloid-lineage specific markers, we used
a radiated, bone marrow (BM) chimeric mouse model;
and we used intracellular cytokine-staining, and double
immunofluorescence staining. In addition, since CD11b
is expressed by both macrophages and granulocytes
[21,22], we also analyzed cytokine production by granu-
locytes using the granulocyte specific marker Gr1. Our
results show that IL-1β and TNF-α are produced by largely
segregated subsets of microglia and macrophages, and
that very few cells express both cytokines.
Methods
Animals
Breeding pairs of CD45.1+  (B6.SJL-Ptprca  Pepcb/BoyJ)
mice and CD45.2+ C57BL/6-Tg(UBC-GFP)30Scha/J (GFP-
Tg) [23] mice were purchased from the Jackson Labora-
tory (Bar Harbour, Maine, USA) and transferred to the
Department of Medical Microbiology and Immunology,
University of Aarhus, where they were maintained as a
colony. GFP-Tg mice, which express the CD45.2+ allotype,
were used as BM donors and congenic BoyJ male mice,
which express the CD45.1+ allotype, were used as BM
recipients. This combination of mice was chosen so that
infiltrating cells could be identified by two different mark-
ers (GFP+ and CD45.2+), however the GFP signal alone
proved to be sufficiently strong and reliable [24] to iden-
tify infiltrating cells. Peritoneal macrophages were
obtained from C57BL/6 mice, which were purchased
from Taconic (Ry, Denmark). Mice were housed under
diurnal lightning conditions with free access to food and
water. The experiments were approved by the Danish Ani-
mal Inspectorate (J. no. 2005/561–1068).
Generation of bone marrow chimeras
BM cells from GFP-Tg mice were grafted into lethally irra-
diated mice as described by Wirenfeldt et al. [24]. For
donor BM recovery, the proximal and distal ends of tibia
and femur were removed and BM was flushed from the
medullary channel into sterile 50 mL polypropylene tubes
using cold RPMI 1640 medium (Gibco, Paisley, UK). The
BM cells were rinsed in RPMI medium and centrifuged at
1,000 rpm for 10 min, then filtered through a sterile cot-
ton sieve. After 3 rounds of rinsing and filtering, cells were
kept on ice until use. Recipient mice (6–8 weeks of age)
were lethally irradiated with a single dose of 9.5 Gy from
a 137Cs source (Risø National Laboratory, Roskilde, Den-
mark). Within 2 hours of irradiation, BM cells were
injected into the tail veins of recipient mice (approxi-
mately 107 cells/mouse). For 3 days after grafting, mice
received oxytetracycline (2 g/L Terramycin vet. 20%;
Pfizer, Amoise, France) in autoclaved drinking water.
Thereafter they were supplied with acidified water (pH 3).
The mice were fed irradiation-sterilized mouse chow and
maintained under pathogen-free conditions for 6 weeks
until they were subjected to surgery.
Permanent middle cerebral artery occlusion
Under anaesthesia, mice were subjected to focal cerebral
ischemia by permanent occlusion of the distal part of the
left middle cerebral artery (pMCAO), as previously
described [20]. During surgery, mice were placed on a
37°C ± 0.5°C warm heating pad. An incision was made
from eye to ear, the parotid gland and the upper part of
the temporal muscle were split, and a small hole was
drilled over the distal part of the MCA. The MCA was
occluded by electrocoagulation and the incision was
stitched with a 4.0 nylon-suture. After surgery, mice were
injected with 1 ml of isotonic saline and their eyes were
coated with ointment. Mice were kept at 28°C until sacri-
ficed, 24 hours post-surgery. For post-surgical analgesia
mice were treated with Temgesic (0.001 mg/20 g
buprenorphinum, Reckitt & Colman, Hull, UK) three




Mice were anesthetized i.p. with an overdose of pentobar-
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of Soerensen's phosphate buffer (SB) (0.03 M KH2PO4
and 0.12 M Na2HPO4, pH 7.4) followed by 20 ml of cold
4% paraformaldehyde (PFA) in 0.15 M SB, pH 7.4. The
brains were post-fixed in 4% PFA for 1 hour followed by
immersion in 20% sucrose in 0.15 M SB overnight. Next,
the brains were frozen and cut into 16-μm frontal sec-
tions. For verification of chimerism in BM-chimeric mice,
samples of spleen, heart, kidney and liver were frozen and
processed to obtain 16-μm cryostat sections.
Cell culture preparation
Thioglycolate-elicited peritoneal macrophages were
obtained after i.p. injection of 1 ml 3% thioglycolate
(Sigma) into C57BL/6 mice. Three days after injection, the
mice were killed by cervical dislocation and 10 ml Dul-
becco's modified Eagle Medium (Invitrogen) was injected
into the peritoneum. Subsequently, the peritoneal fluid
was withdrawn. After two washes in phosphate buffered
saline (PBS, pH 7.4) the cells were counted and plated in
T25 flasks in DMEM Medium containing 5% FBS, 100
units/ml of penicillin, and 100 mg/ml streptomycin
(Sigma). The macrophages were kept in a humidified
37°C incubator with 5% CO2 for 2 days and then stimu-
lated for 24 hours with 100 ng/ml LPS (Sigma).
Flow cytometry
Mice were perfused through the left ventricle using 10 ml
PBS, whereafter the ipsi- and contralateral cortices were
isolated. Infarcts were macroscopically visible at 6, 12 and
24 hours post-occlusion, verifying successful occlusion of
the MCA. Blood samples were collected in heparinized
Eppendorf tubes and Hanks' balanced salt solution
(HBSS: 0.14 M NaCl, 5.4 mM KCl, 0.4 mM MgSO4￿7H2O,
0.4 mM Na2HPO4(anhydrate), 1.3 mM CaCl22H2O, 4.2
mM NaHCO3, 0.4 mM KH2PO4, 0.5 mM MgCl26H2O,
and 5 mM glucose) for validation of BM reconstitution.
Lymph nodes were removed and collected as control tis-
sue.
Immunohistochemistry and cell counting
Immunohistochemistry for CD11b, CD45, IL-1β and TNF-α
Microglial/macrophage staining by CD11b or CD45 was
done using an streptavidin/horseradish peroxidase tech-
nique as previously described [20]. Immunohistochemi-
cal stainng for IL-1β and TNF-α was performed as
previously described [12,14] (Table 1).
Immunohistochemistry for GFP+ cells
To detect infiltrating GFP+ cells, sections were rinsed 3 ×
15 min in 0.05 M Tris-buffered saline (TBS, pH 7.4), and
endogenous peroxidase activity was blocked by rinsing
the sections in 30% H2O2, methanol and TBS (1:1:8) for
30 min at room temperature (RT). After rinsing 2 × 10
min in TBS + 0.5% Triton, the sections were incubated
with 10% fetal calf serum (FCS) in TBS for 30 min at RT
to reduce non-specific staining. Sections were then incu-
bated with rabbit anti-GFP (Table 1, Abcam) diluted
1:1,000 in TBS containing 10% FCS overnight at 4°C.
Next, sections were rinsed 3 × 15 min in TBS + 0.5% Triton
and incubated with peroxidase-labeled "ready-to-use"
EnVision+ polymer (DakoCytomation) overnight at 4°C.
Sections were then rinsed 3 × 15 min in TBS and devel-
oped for 7 min in TBS containing 0.05% diaminobenzi-
dine and 0.033% H2O2. Finally, sections were rinsed in
TBS, dehydrated in a graded series of alcohol, cleared in
xylene and mounted in Depex. Antibody specificity was
assessed by negative controls using substitution of the pri-
mary antibody with rabbit IgG (Table 1, DakoCytoma-
tion) or omission of the primary antibody. These sections
were devoid of signal.
Double immunofluorescence staining for cell specific markers and IL-
1β and/or TNF-α
Sections were air dried, rinsed in TBS for 10 min, and
blocked with 10% FCS in TBS + 0.5% Triton for 30 min at
RT. Next, the sections were incubated with primary anti-
body (Table 1) overnight at 4°C, followed by rinsing for
10 min in TBS and incubation with a species-specific sec-
ondary fluorescent antibody (Table 1) diluted 1:200 for
1–2 hours the next day. From this point forward, the sec-
tions were protected from light. After 10 min in TBS, sec-
tions were incubated for 2 hours with the second primary
antibody diluted in TBS + 0.5% Triton containing 10%
FCS, rinsed in TBS for 10 min at RT, and then incubated
with the secondary antibody diluted 1:200 in TBS + 0.5%
Triton containing 10% FCS for 1–2 hours at room temper-
ature (RT). Finally, sections were rinsed 2 × 10 min in TBS,
followed by 2 × 10 min in distilled H2O, and mounted in
ProLong® Gold antifade reagent with DAPI (Invitrogen,
Taastrup, Denmark). Negative controls, where primary
antibodies were replaced by isotype controls (Table 1) or
omitted from the protocol, were devoid of signal.
Estimation of numbers of infiltrating GFP+ cells
The number of GFP+ cells in the ipsilateral cortex was esti-
mated using the cell counting method described in Lam-
bertsen et al. [25]. GFP+ cells with an identifiable nucleus
were counted in approximately 16 sections from each ani-
mal, 384 μm apart. This was done using a 100× objective
and a 25% frame area, stepping 300 μm/300 μm in the x-
y position using the CAST Grid System from Olympus.
The total number (N) of GFP+ cells in each animal was
estimated using the formula: Estimate of N = ΣQ × (1/ssf)
× (1/asf) × (1/tsf), where Q was the number of cells
counted, 1/ssf the sampling section fraction (1/ssf = 24),
and 1/asf the area sampling fraction (1/asf = 36.4) [26].
The thickness sampling fraction (1/tsf) was set to 1, since
cells were counted in the entire height of the sections [25].Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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Flow cytometry
Preparation of cell suspensions
Tissues from individual mice were processed separately.
Single-cell suspensions of ipsi- or contralateral cortices or
lymph nodes were obtained by homogenisation using 70-
μm nylon cell strainers (BD Falcon, Franklin Lakes, NJ,
USA) [24,27], in RPMI containing 10% FCS and 1 μl/ml
BD GolgiPlug™ with Brefeldin A (BD Biosciences). Cells
were transferred to sterile petri dishes and placed in a
37°C incubator with 5% CO2 for 4 1/2 hours. Cell sus-
pensions were transferred to polystyrene tubes and pel-
leted by centrifugation (1,400 rpm for 6 min at 4°C).
Table 1: Antibodies applied for flow cytometry, immunohistochemistry and fluorescence stainings.
Cell population Antibody Isotype Species of origin Cat. #
Flow cytometry:
T-cells TCRβ-APC IgG2 Hamster 553174, BD Biosciences*
Granulocytes GR1-FITC IgG2b Rat 553126, BD Biosciences
TNF producing cells TNF-PE IgG1 Hamster 559503, BD Biosciences
IL-1β producing cells IL-1β Rabbit AAM13G, Serotec
Microglia/macrophages CD11b-PE/-APC/-PerCP-Cy5.5 IgG2b Rat 557397/553312/550993, BD*
Microglia/macrophages CD45-PE/-APC/-PerCP-Cy5.5 IgG2b Rat 553081/559864/550994, BD*
Isotype/serum controls: PE-/APC-/PerCP-Cy5.5-conjugated IgG2b Rat 553989/556924/550764, BD*
FITC-conjugated IgG2b Rat 556923, BD Biosciences
PE-conjugated IgG1 Hamster 554711, BD Biosciences
APC-conjugated IgG2 Hamster 558141, BC Biosciences
Un-conjugated Ig fraction Rabbit X0903, DakoCytomation
Secondary antibodies:
Anti-rabbit I Alexa Fluor647-conjugated IgG Goat A21244, Invitrogen
Anti-rabbit II Alexa Fluor488-conjugated IgG Chicken A21441, Invitrogen
Immunohistochemistry:
BM-derived cells GFP (1:1000) Rabbit ab290, Abcam
TNF producing cells TNF (1:50) Rat MM-350, Endogen
TNF producing cells TNF (1:200) Rabbit P-350, Endogen
IL-1β producing cells IL-1β (1:50) Rabbit AAM13G, Serotec
Microglia/macrophages CD11b (1:600) IgG2b Rat MCA711, Serotec
CD45.1 Biotin-conjugated (1:80) IgG2a,κ Mouse 553774, BD Biosciences
CD45.2 Biotin-conjugated (1:80) IgG2a,κ Mouse 553771, BD Biosciences
CD45 (1:80) IgG1 Rat MCA1388, Serotec
Granulocytes Ly-6G and Ly-6C(Gr1) (1:200) IgG2b Rat 01211A, BD Biosciences
Endothelial von Willebrandt's Factor (1:200) Rabbit A0082, DakoCytomation
Endothelial PECAM-1/CD31 (1:100) IgG2a Rat 557355, BD Biosciences
Astrocytes GFAP (1:1,200) Rabbit Z0334, DakoCytomation
Astrocytes GFAP (1:50) Goat sc-6170, Santa Cruz
Biotechnology
Isotype/serum controls: Un-conjugated IgG2b Rat IG-851125, Biosite
Un-conjugated IgG2a Rat P54605M, Biosite
Un-conjugated Serum Goat X0907, DakoCytomation
Un-conjugated Ig fraction Rabbit X0903, DakoCytomation
Biotin-conjugated IgG2a,κ Mouse 553455, BD Biosciences
Secondary antibodies:
Anti-rabbit IgG Alexa Fluor594-conjugated (1:200) Donkey A21207, Invitrogen
Anti-rabbit IgG Alexa Fluor546-conjugated (1:200) Goat A11010, Invitrogen
Anti-rabbit IgG Alexa Fluor488-conjugated (1:200) Goat A11070, Invitrogen
Anti-rabbit IgG Alexa Fluor488-conjugated (1:200) Chicken A21441, Invitrogen
Anti-rat IgG Alexa Fluor568-conjugated (1:200) Goat A11077, Invitrogen
Anti-rat IgG Alexa Fluor594-conjugated (1:200) Goat A11007, Invitrogen
Anti-rat Ig Alexa Fluor488-conjugated (1:200) Goat A11006, Invitrogen
Streptavidin HRP-conjugated Streptavidin (1:200) P0397, DakoCytomation
PE: phycoerythrin, PerCP-Cy5.5: perinidin chlorophyll protein-cyanine5.5, APC: allophycocyanin, FITC: fluorescein isothiocyanate, vWF: von 
Willebrandt's Factor, PECAM-1: platelet endothelial adhesion molecule-1, GFAP: glial fibrillary acidic protein, GFP: green fluorescent protein.Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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Staining procedures
Cells were incubated for 30 min in staining-buffer (stain-
ing-buffer: Hank's Buffered Salt Solution with 2% FCS
and 0.1% sodium azide), containing 50 μg/ml Syrian
hamster Ig (Jackson Immunoresearch, West Grove, PA,
USA) and 1 μg/ml anti-FcγIII/II receptor (BD FcBlock™,
BD Biosciences), to block non-specific staining. After rins-
ing, cells were stained for surface antigens (or their isotype
controls) (Table 1) for 30 min at RT, and then rinsed in
staining-buffer [24,27]. Following staining of surface
markers (CD11b, CD45, Gr1, TCRβ), the cells were fixed
and permeabilized in Cytofix/Cytoperm™ (BD Bio-
sciences) for 20 min at 4°C, washed in 1 ml 1× Per-
mWash™ buffer (BD Biosciences), and incubated with
antibodies recognizing intracellular antigens (IL-1β, TNF-
α or isotype controls) (Table 1) for 30 min at RT. Cells
stained with unconjugated antibodies were rinsed, then
incubated with fluorescently labelled goat anti-rabbit sec-
ondary antibodies for 30 min at RT. After the final rinse,
cells were resuspended in staining-buffer.
Blood
For blood samples, cells were stained using antibodies
recognizing CD11b, CD45 and TCRβ (Table 1), as
described for brain homogenates. Red blood cells were
then lysed using Serotec Erythrolyse Red Blood Cell buffer
(Serotec) diluted 1:10 in distilled water for 7 min at RT.
Finally, cells were rinsed three times and resuspended in
staining-buffer.
Flow cytometric analysis
Staining was analyzed using a FACSCalibur flow cytome-
ter and CellQuest Pro Software (BD Biosciences). Estima-
tion of numbers of cells was done as previously described
[24,27]. Data are presented as an average of these num-
bers. Preparation and staining of cortical homogenates
inevitably resulted in cell loss, and the cell numbers and
proportions presented are based on cells remaining in sus-
pension. For analysis of microglia and macrophages/gran-
ulocytes, cells were gated on side scatter (SSC) versus
CD11b, followed by forward scatter (FSC) versus CD11b,
and FSC versus CD45. Microglia were separated from
macrophages/granulocytes based on CD45 expression,
with intermediate levels of CD45 (CD45dim) identifying
CD11b+ parenchymal microglia, and high levels of CD45
(CD45high) identifying CD11b+ macrophage/granulocytes
[28]. GFP+, Gr1+, IL-1β+ and TNF-α+ cells were identified
on additional colour channels. GFP+ BM-derived cells
were separated from GFP- resident cells based on GFP
expression. For quantification of IL-1β/TNF-α co-expres-
sion, resident microglia (GFP-CD45dim) and infiltrating
leukocytes (GFP+CD45high) were gated on SSC versus
CD45 followed by FSC versus CD45. For analysis of
expression of IL-1β and TNF-α in TCRβ+ T cells, cells were
gated on SSC versus CD45 followed by FSC versus CD45.
IL-1β+, TNF-α+ and TCRβ+ cells were identified on addi-
tional colour channels. Positive staining was determined
based on fluorescence levels of isotype controls or
autofluorescence controls (for GFP).
Data analysis
Histology results were documented using an Olympus
DP70 digital camera mounted on an Olympus BX51
microscope connected to a PC with Olympus DP-soft-
ware. Figures were organized using Adobe Photoshop CS.
The data were evaluated using Kruskal-Wallis test (non-
parametric ANOVA) with Dunn's multiple comparison
test as follow-up test. Comparisons of mean values
between two groups of mice were done using the non-par-
ametric Mann-Whitney test using the GraphPad Prism
4.0b software for Macintosh, GraphPad Software, San
Diego, California, USA. Data are presented as means ± SD.
Statistically significant differences were established at P <
0.05.
Results
Regional distribution of cells producing IL-1β and TNF-α
We have previously shown that IL-1β and TNF-α are pro-
duced by CD11b+ microglia and infiltrating CD11b+ cells,
i.e. macrophages and granulocytes, situated within and at
the edge of the infarct 24 hours after pMCAO in SJL and
C57BL/6 mice [12,14,20]. In line with these observations,
IL-1β- and TNF-α-expressing cells were observed within
and adjacent to the infarct in B6.SJL-Ptrpra Pepcb/BoyJ
mice 24 hours after pMCAO. These cells co-localized with
activated CD11b+ microglia and CD11b+ macrophages/
granulocytes observed in parallel sections (Figure 1A).
Double immunofluorescence staining confirmed that IL-
1β (Figure 1B) and TNF-α Figure 1C) were expressed by
activated CD11b+ microglia and infiltrating CD11b+ mac-
rophages/granulocytes.
Blood-borne, bone marrow-derived cells infiltrate after 
pMCAO
Whole-body irradiated mice were reconstituted with BM
cells from GFP-Tg mice, allowing us to distinguish infil-
trating GFP+CD11b+CD45high BM-derived cells from resi-
dent GFP-CD11b+CD45dim  microglia. Flow cytometric
analysis showed that 97% of nucleated blood cells were
GFP+, providing us with a reliable tool to differentiate
between infiltrating GFP+ BM-derived cells and resident
GFP- cells. Flow cytometric analysis of perfused cortex
from chimeric mice allowed to survive 24 hours after
pMCAO showed a substantial increase in
CD11b+CD45high cell population compared to unmanip-
ulated control chimeras (Figure 2A). As expected, the
majority of CD45high cells were GFP+ (92%), consistent
with these cells being BM-derived (Figure 2B). Investiga-
tion of the CD11b+CD45dim  microglial population
showed that these cells were primarily GFP-. However,Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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there was evidence of injury-induced recruitment of GFP+
microglial precursors (7%) into the ischemic cortex (Fig-
ure 2B, C). Comparison of the CD11b+CD45high cell pop-
ulation in BM-chimeric mice and non-chimeric mice
allowed to survive 24 hours after pMCAO (Figure 2D)
showed similar mean numbers of CD11b+CD45high infil-
trating cells. In contrast, however, the CD11b+CD45dim
microglial population was significantly reduced in BM-
chimeric compared to non-chimeric mice (Figure 2D)
suggesting that whole body irradiation affects the resident
microglial population, independent of injury. Similarly,
the result showed less CD11b+CD45dim microglia in chi-
meric versus unmanipulated non-chimeric mice (Figure
2A and 4A).
The distribution of infiltrating GFP+ cells was visualized
using immunohistochemistry. Twenty-four hours after
pMCAO, GFP+ cells were distributed throughout the inf-
arct, such that the border of the infarct was easily deline-
ated (Figure 2E). The GFP+ cells occurred both as single
cells (Figure 2F), and as vessel-associated aggregates (Fig-
ure 2G). Microscopic analysis of the perivascular vessel-
associated aggregates showed two morphologically differ-
ent cell types; round cells, which appeared to locate to the
Co-expression of IL-1β or TNF-α with CD11b+ cells Figure 1
Co-expression of IL-1β or TNF-α with CD11b+ cells. Cortical infarction 24 hours after pMCAO leads to expression of 
IL-1β and TNF-α in activated CD11b+ microglia and macrophages/granulocytes. (A) Distribution of CD11b+, IL-1β+ and TNF-
α+ cells in infarct (IF) and peri-infarct (P-IF) regions. IL-1β+ (B) and TNF-α+ (C) cells were particularly numerous at the edge of 
the infarct, and these cytokines were exclusively expressed by CD11b+ cells (arrows). CD11b+ cells were visualized using Alexa 
Fluor® 488-conjugated goat anti-rat IgG, IL-1β+ and TNF-α+ cells using Alexa Fluor® 594-conjugated donkey anti-rabbit IgG. 
Scale bars: 200 μm (A), 20 μm (B, C).Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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Figure 2 (see legend on next page)Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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juxtavascular space and to infiltrate the neuropil (Figure
2G), and elongated cells lining the microvascular wall
(insert in Figure 2G). In order to determine the extent of
cellular recruitment, we estimated the total number of
GFP+ cells within the ischemic cortex using both mor-
phometry and flow cytometry. By morphometry, the total
number of single GFP+ cells was estimated to be 130,000
± 24,000 (mean ± SD) cells (Figure 2H). The number of
vessel-associated aggregates of GFP+ cells were quantified
separately (8,000 ± 2,200) (Figure 2H). Only a few GFP+
single cells were present in the cortex of the contralateral
hemisphere (Figure 2H), or in brains from unmanipu-
lated BM-chimeric mice. GFP+ cells were identified in sec-
tions from all organs from BM-chimeric mice (data not
shown). Using flow cytometry, we estimated the total
number of GFP+ cells within the isolated cortex to be
42,655 ± 23,465 (mean ± SD) cells (Figure 2C), which
corresponded to 33% of the number of GFP+ cells esti-
mated by morphometry (Figure 2H).
Because we observed a reduced number of
CD11b+CD45dim microglia after pMCAO in BM-chimeric
mice versus non-chimeric mice (Figure 2D), we investi-
gated whether irradiation affected cellular CD45 expres-
sion resulting in incorrect estimation of cell numbers.
Immunohistochemical stainings for CD45.1 (Figure 2I,
K) and CD45.2 (Figure 2J, L) confirmed the presence of
donor-derived CD45.2+ cells within the ischemic cortex of
BM-chimeric mice (Figure 2J) but not in non-chimeric
mice (Figure 2L). Similarly, we found no evidence of
altered CD45 expression when comparing stainings with
a generally expressed CD45 marker in chimeric and non-
chimeric mice 24 hours after pMCAO (Figure 2N, P). Flu-
orescence microscopy confirmed that the majority of
GFP+ cells were CD11b+ (Figure 3A), thereby showing that
they were myeloid lineage-derived macrophages/granulo-
cytes. This was additionally emphasized by the staining
for the endothelial markers von Willebrand Factor (vWF)
and platelet endothelial cell adhesion molecule-1
(PECAM or CD31), which appeared to be expressed
largely by GFP- cells (Figure 3B, C).
Kinetics of the microglial and macrophage/granulocyte 
response
Having shown that the vast majority of the
GFP+CD11b+CD45+cells were infiltrating BM-derived
macrophages/granulocytes, and that almost all
CD11b+CD45dim cells were resident microglia, we investi-
gated the kinetics of microglial activation and cell infiltra-
tion after pMCAO in non-chimeric mice, using CD45
levels to distinguish resident CD45dim  microglia from
infiltrating CD45high macrophages/granulocytes by flow
cytometry (Figure 4A–D). Estimation of the numbers of
CD11b+CD45dim  microglia revealed comparable cell
numbers in brains of unmanipulated mice and mice after
6 hours of survival, whereas there was a significant
increase in microglia 12 hours or 24 hours after pMCAO
(Figure 4E). As expected, the numbers of microglia in
sham-operated mice remained unaffected at 24 hours
(Figure 4E). Furthermore, CD11b+CD45high  macro-
phages/granulocytes increased in numbers over the
period from 6 to 24 hours post-occlusion, compared to
unmanipulated controls and sham-operated mice at 24
hours (Figure 4E). Two populations of CD11b+CD45high
cells were visible on flow cytometric dot plots from mice
exposed to 24 hours of pMCAO, which differed by
expressing intermediate or high levels of CD11b (Figure
4C). Since CD11b is expressed both on macrophages and
granulocytes [21,22], we investigated whether and to
what extent CD45+Gr1+ granulocytes contributed to the
CD11b+CD45high cell population (Figure 4D, F). There
was significant infiltration by granulocytes as early as 6
hours compared to unmanipulated control mice (Figure
4F). By 24 hours, there was an additional pMCAO-
induced increase in CD45+Gr1+ cells compared to sham-
operated mice with 24 hours survival. Similar numbers of
Infiltration of GFP+ BM-cells in infarct and peri-infarct regions Figure 2 (see previous page)
Infiltration of GFP+ BM-cells in infarct and peri-infarct regions. (A-B) Dot plots of viable macrophages/granulocytes 
(CD11b+CD45high, top right quadrants) and microglia (CD11b+CD45dim, bottom right quadrants) in cortex from BM-chimeric 
unmanipulated mice and mice exposed to pMCAO. (C) Bar graph showing mean numbers of CD11b+CD45dim microglia and 
CD11b+CD45high macrophages/granulocytes in BM-chimeric mice 24 hours after pMCAO, subdivided based on expression of 
GFP (n = 5). Approximately 92% of of the CD45high population were GFP+ . (D) Estimation and comparison of mean numbers 
of CD11b+CD45dim microglia in non-chimeric (n = 10) versus BM-chimeric mice (n = 5) 24 hours after of pMCAO shows sig-
nificantly fewer CD11b+CD45dim microglial cells in irradiated mice. (E) Overview, showing distribution of infiltrating GFP+ BM-
derived cells into infarct (IF) and peri-infarct (P-IF) regions 24 hours after pMCAO. (E-G) By 24 hours, GFP+ single cells (F) and 
vessel-associated aggregates of GFP+ cells (arrows in G) were observed in infarct and peri-infarct regions. Some of the vessel-
associated cells were round, leukocyte-like cells (arrows) while others were elongated cells lining the vasculature (arrow heads 
in G and in insert). (H) Bar graph showing mean numbers of single GFP+ cells and vessel-associated aggregates of GFP+ cells in 
ipsi- and contralateral cortex 24 hours after surgery (n = 10). (I-P) Immunohistochemical staining of CD45.1 (I, K), CD45.2 (J, 
L), IgG2a (M, O) and CD45 (N, P) in ischemic tissue in BM-chimeric (I, J, M, N) and non-chimeric mice (K, L, O, P) 24 hours 
after pMCAO. N.D, none detected. Scale bars: 200 μm (A), 10 μm (B, C). 50 μm (I-P) *P < 0.05, **P < 0.01, and ***P < 0.001.Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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CD45+Gr1+granulocytes and CD45+Gr1-  macrophages
were recruited to the ischemically injured cortex, and
these populations shared the same temporal profile (Fig-
ure 4F).
Finally, since microglia become activated by stroke
[14,20], and evidence shows that CD45 is inducible in
microglia [29], we investigated whether cellular levels of
CD45 expression were affected by the ischemic insult. For
this, we analysed mean fluorescence intensity (MFI) of the
CD45 signal on CD11b+CD45dim  microglia and
CD11b+CD45high macrophages/granulocytes. MFI values
were obtained for unmanipulated controls, in mice with
6-, 12-, and 24-hour survivals, and in sham-operated mice
at 24 hours. We observed a significant upregulation of
CD45 on microglia by 12 hours, which reached peak lev-
BM-derived GFP+ single cells and vessel-associated cells express CD11b Figure 3
BM-derived GFP+ single cells and vessel-associated cells express CD11b. Fluorescence microscopy for GFP com-
bined with immunofluorescence detection of (A) CD11b, (B) vWF and (C) CD31, 24 hours after pMCAO. (A) Fluorescence 
detection of GFP and CD11b showed that most GFP+ cells co-expressed CD11b (yellow cells, indicated by arrows), and inter-
mingled with CD11b+ host cells. Note also that a few GFP+ cells did not co-express CD11b (arrow head). Insert shows high 
magnification of GFP+ cells, some of which co-express CD11b, aggregated around a vessel. (B, C) Fluorescence detection of 
GFP and the endothelial cell markers vWF (B) and CD31 (C). Inserts show higher magnification of sections of the same vessels. 
Although there are indications that single vWF+ cells co-express GFP (arrows in B), this could not be reproduced using staining 
for CD31, and the majority of vWF+ and CD31+ cells showed no co-expression of GFP. Instead, GFP remained confined to 
round and elongated cells located in the juxtavascular space (insert in C). CD11b+ cells were visualized using Alexa Fluor® 568-
conjugated goat anti-rat IgG, vWF+ and CD31+ cells using Alexa Fluor® 546-conjugated goat anti-rabbit IgG and Alexa Fluor® 
594-conjugated goat anti-rat IgG, respectively. Scale bars: 20 μm (A-C).Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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els 24 hours after pMCAO compared to unmanipulated
controls and sham-operated mice (Figure 4G). Similarly,
CD45 levels were increased on infiltrating macrophages/
granulocytes by 24 hours compared to unmanipulated
control and sham-operated mice (Figure 4H).
IL-1β and TNF-α are expressed by largely non-overlapping 
subsets of cells
Next we used flow cytometry to determine which cell pop-
ulation(s), the resident CD11b+CD45dim microglia or the
infiltrating CD11b+CD45high macrophages/granulocytes,
or both, expressed IL-1β, TNF-α, or a combination of IL-
1β and TNF-α after pMCAO (Figure 5A, B). Numbers of
IL-1β-expressing CD11b+CD45dim microglia and infiltrat-
Inflammatory response following permanent MCA occlusion Figure 4
Inflammatory response following permanent MCA occlusion. (A-C) Dot plots of viable CD11b+CD45high macro-
phages/granulocytes (top right quadrants) and CD11b+CD45dim microglia (bottom right quadrants) in cortex from unmanipu-
lated control mice (A, B), and mice exposed to pMCAO with 24 hour survival (C). (D) At 24 hours, flow cytometric analysis of 
the CD11b+CD45high profiles showed that approximately half of the population consisted of CD45highGr1+ granulocytes. (E) 
Quantification of CD11b+CD45dim and CD11b+CD45high cells in unmanipulated control mice (n = 10), in mice 6 (n = 7), 12 (n = 
7), or 24 hours after pMCAO (n = 10), and in sham-operated mice 24 hours after pMCAO (n = 7). (F) Bar graphs showing 
equal recruitment of CD11b+CD45highGr1- macrophages and CD11b-CD45highGr1+ granulocytes in unmanipulated mice, in 
mice 6, 12, or 24 hours after pMCAO, and in sham-operated mice 24 hours after pMCAO. (G, H) Bar graphs showing the 
mean fluorescent intensity (MFI) of CD45 expression by CD45dim microglia (G) and CD45high macrophages/granulocytes (H). 
*P < 0.05, **P < 0.01, and ***P < 0.001.Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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ing CD11b+CD45high macrophages/granulocytes peaked
between 12 and 24 hours after pMCAO (Figure 5C). The
proportion of IL-1β-expressing CD11b+CD45dim micro-
glia increased from 3% of the total microglial population
in unmanipulated mice to 15% of the total microglial
population 24 hours after pMCAO (Figure 5D). In addi-
tion, the proportion of IL-1β-expressing CD11b+CD45high
macrophages/granulocytes increased from 3% in unma-
nipulated mice to 29% by 12 hours, then decreased to
17% of the total macrophage/granulocyte population
after 24 hours of pMCAO (Figure 5D). MFI values for IL-
1β showed increased protein expression by CD11b+CD4
5dim microglia and infiltrating CD11b+CD45high macro-
phages/granulocytes after 24 hours of pMCAO (Figure
5E).
The time profile for TNF-α-expressing CD11b+CD45dim
microglia showed a significant increase in numbers of
TNF-α+ cells at 12 hours, which peaked 24 hours after
pMCAO compared to unmanipulated control mice. Simi-
larly there was a injury-induced increase in numbers of
CD11b+CD45high  macrophages/granulocytes that
expressed TNF-α at 24 hours after pMCAO (Figure 5F).
Calculation of the proportion of TNF-α-expressing
CD11b+CD45dim microglia and CD11b+CD45high macro-
phages/granulocytes showed that the proportion of TNF-
α+ microglia peaked with 2% of the CD11b+CD45high
population at 12–24 hours after pMCAO, while the pro-
portion of TNF-α+ macrophages/granulocytes was 17% of
the CD11b+CD45high population in unmanipulated con-
trols and 4% at 24 hours after pMCAO. This most of all
reflected that a relatively large proportion of the very few
CD11b+CD45high  cells present in the unmanipulated
mouse cortex expressed TNF-α (Figure 5G). Generation of
MFI values for TNF-α showed a significant increase in the
amount of TNF-α expressed by microglia by 12 and 24
hours compared to unmanipulated control mice. In con-
trast, the level of TNF-α expression by CD11b+CD45high
macrophages/granulocytes seemed unaffected by
ischemic injury (Figure 5H).
We additionally identified a subpopulation of
CD11b+CD45dim microglia and CD11b+CD45high macro-
phages/granulocytes that co-expressed IL-1β and TNF-α
(Figure 5I). The proportion of IL-1β/TNF-α co-expressing
microglia increased from 0.05% in unmanipulated con-
trols to 1.2% after 24 hours of pMCAO, whereas co-
expressing macrophages doubled from 2% in unmanipu-
lated controls to 4% after 12 hours of pMCAO, before
declining to 2% after 24 hours (Figure 5J).
Interestingly, the proportions of IL-1β-, TNF-α-, and IL-
1β/TNF-α-expressing macrophages/granulocytes were rel-
atively high in sham-operated mice (Figure 5D, G, J).
However, since the number of CD11b+CD45dim micro-
glia and CD11b+CD45high macrophages/granulocytes
did not differ between unmanipulated controls and sham-
operated mice (Figure 4E), the overall number of cytokine
expressing cells was much lower in sham-operated versus
pMCAO operated mice (Figure 5C, F, I).
Taken together, these results clearly show that largely non-
overlapping subsets of microglia and macrophages/gran-
ulocytes produce IL-1β and TNF-α after pMCAO in mice.
Finally, since both macrophages and granulocytes express
CD11b and high levels of CD45 [21], we used Gr1 to
determine which cell population was the predominant
CD45high source of IL-1β and TNF-α. We found a small
but significant increase in both IL-1β- and TNF-α express-
ing CD45highGr1+ granulocytes at 24 hours after pMCAO
compared to unmanipulated control mice. However, the
CD45highGr1- macrophages were clearly the major pro-
ducers of both IL-1β and TNF-α (Figure 5K). A small
number of CD45high  cells identified as T cells
(TCRβ+CD45high) was also observed. The number of T
cells in ischemic cortex by 6, 12 and 24 hours did not dif-
fer from the number in cortex of unmanipulated or sham-
operated mice (< 200), and none of the TCRβ+CD45+ T
cells were observed to express either IL-1β or TNF-α (data
not shown).
Comparison of cytokine expression in LPS-stimulated and 
ischemia-activated macrophages
To further verify our findings, we compared the intensity
of the fluorescent cytokine signal between macrophages
obtained from mice after 24 hours of pMCAO and LPS-
stimulated, thioglycolate-elicited peritoneal macro-
phages, used as a positive control for IL-1β and TNF-α
expression. Histograms shown in Figure 6 demonstrate a
clear shift from the respective control antibody (IgG) for
both IL-1β (Figure 6A) and TNF-α (Figure 6B). Determi-
nation of the MFI showed that the LPS-stimulated perito-
neal macrophages expressed lower levels of IL-1β (MFI:
85.28, (IgG: 49.23)) than did ischemia-activated macro-
phages (MFI: 104.03 (IgG: 46.06)) whereas LPS-stimu-
lated peritoneal macrophages expressed higher levels of
TNF-a (MFI: 53.84, (IgG: 14.79)) than did ischemia-acti-
vated macrophages (MFI: 39.28 (IgG: 24.11)).
Expression of IL-1β and TNF-α by Gr1-CD11b+ microglia 
and macrophages
The flow cytometry data presented above show that
microglia and macrophages, but not granulocytes, are
major producers of IL-1β and TNF-α, and that co-expres-
sion of IL-1β and TNF-α is limited to a small subset of
microglia and macrophages. We then validated these
results using double-immunofluorescence of tissue sec-
tions, to distinguish resident microglia from infiltrating
cells in BM-chimeric mice. Because a subpopulation of theJournal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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Figure 5 (see legend on next page)Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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infiltrating GFP+ cells were identified as granulocytes (Fig-
ure 7A), we first investigated if Gr1+ granulocytes express
IL-1β and TNF-α by using double immunofluorescence.
We found that neither IL-1β nor TNF-α was expressed by
Gr1+ granulocytes (Figure 7B). This might reflect the lower
sensitivity of immunohistochemistry compared to flow
cytometry, or may indicate that granulocytes express
smaller amounts of protein (IL-1β MFI: 58 ± 18; TNF-α
MFI: 27 ± 2) than do macrophages (IL-1β MFI: 104 ± 25;
TNF-α MFI: 40 ± 2) (P < 0.004). Double-immunofluores-
cence staining identified both resident and infiltrating
cells expressing either IL-1β (Figure 7C) or TNF-α (Figure
7D), but only rarely identified cells co-expressing IL-1β
and TNF-α 24 hours after pMCAO (Figure 7E), confirming
the flow cytometric data. There was no co-localization of
IL-1β or TNF-α staining with the astroglial marker GFAP
(data not shown) or with the endothelial markers vWF/
CD31 (data not shown).
Discussion
We have shown for the first time that IL-1β and TNF-α are
produced by largely non-overlapping subsets of microglia
and macrophages after induction of ischemic stroke in
mice. Using flow cytometry and histology, validated by
the use of BM-chimeric mice, we showed that microglia
and macrophages are the major producers of IL-1β and
TNF-α after pMCAO, and that at maximum 1.2% of
microglia and 4.5% of infiltrating macrophages co-
express IL-1β and TNF-α within the first 24 hours after
pMCAO. Granulocytes, which accounted for 50% of the
CD11b+CD45high cell population and which are known to
exacerbate ischemic brain damage [30], accounted for
only 2.4% of IL-1β and 0.8% of TNF-α expression by
CD11b+CD45high cells after 24 hours of pMCAO, indicat-
ing that the contribution of these cells to the production
of IL-1β and TNF-α after pMCAO in mice is negligible. A
scenario therefore emerges wherein different subsets of
microglia and macrophages may have different roles in
ischemic stroke, and may thus either improve or reduce
the chance of survival of ischemic neurons.
Our observation of a peak in the total number of IL-1β-
and TNF-α-expressing cells 24 hours after pMCAO is in
line with previous demonstrations of a time-dependent
peak in the number of IL-1β mRNA-, TNF-α mRNA-, and
TNF-α protein-expressing cells in SJL and C57BL/6 mice,
12–24 hours after pMCAO [12,14,25]. By taking advan-
tage of the ability of flow cytometry to distinguish
between CD11b+CD45dim  microglia and infiltrating
CD11b+CD45high  macrophages, we showed that the
number of IL-1β- and TNF-α-expressing microglia by far
exceeded the number of cytokine-expressing macrophages
12 hours after pMCAO. This result was expected based on
the known steady increase in the number of infiltrating
macrophages over the first 24 hours of pMCAO, but this
result has not been previously demonstrated.
It was striking to observe that a relatively large proportion
of the small number of macrophages present in the cortex
from unmanipulated mice express TNF-α, and that the
MFI levels of TNF-α expression in these cells are compara-
ble to mean cellular TNF-α expression levels in pMCAO
and sham-operated mice. This indicates that TNF-α
expression by macrophages is relatively constant no mat-
ter whether the cells have infiltrated the cortex prior to or
after pMCAO. Interestingly, the proportion of cytokine-
expressing macrophages in sham-operated mice was at
least as high as that in mice subjected to pMCAO. This
likely reflects that sham surgery in itself induces a focal
lesion in the cortex [12,14]. It is important to note, how-
ever, that overall numbers of cytokine-expressing macro-
phages are not increased versus control mice, since there
was no significant recruitment of CD11b+CD45high cells to
the cortex of sham-operated mice.
Permanent MCAO results in formation of a pan-necrotic
infarct, with loss of all cell types including microglial cells.
Although neurons and microglia can still be clearly
detected after 6 hours of pMCAO [12,14], the developing
infarct is usually characterised by severe cell loss 12 hours
after pMCAO [12,14,20] We were therefore surprised not
Cytokine expression in segregated populations of cells following stroke Figure 5 (see previous page)
Cytokine expression in segregated populations of cells following stroke. (A, B) Dot plots showing CD11b+CD45high 
macrophages/granulocytes (upper right quadrants) and CD11b+CD45dim microglia (bottom right quadrants) expressing IL-1β 
(A) or TNF-α (B). (C-J) Bar graphs showing numbers and proportions of IL-1β (C, D), TNF-α (F, G) and IL-1β/TNF-α co-
expressing (I, J) CD11b+CD45dim microglia and CD11b+CD45high macrophages/granulocytes in unmanipulated control mice (n 
= 10), in mice 6 (n = 7), 12 (n = 7), or 24 hours after pMCAO (n = 10), and in sham-operated mice 24 hours after pMCAO (n 
= 7). (E, H) Comparison of the MFI values for IL-1β (E) and TNF-α (H) in viable CD11b+CD45dim microglia and 
CD11b+CD45high macrophages/granulocytes in unmanipulated mice, in mice 6, 12, or 24 hours after pMCAO, and in sham-
operated mice 24 hours after pMCAO. Macrophages/granulocytes express significantly more IL-1β than do microglial in unma-
nipulated mice, in mice 6, 12, or 24 hours after pMCAO, and in sham-operated mice 24 hours after pMCAO (E), whereas 
microglial cells express significantly higher levels of TNF-α than do macrophages/granulocytes at 12 h and 24 hours, and in 
sham-operated mice 24 hours after pMCAO (H). (K) CD11b+CD45highGr1- macrophages and not CD11b+CD45highGr1+ gran-
ulocytes are the main producers of IL-1β and TNF-α 24 hours after pMCAO. *P < 0.05, **P < 0.01, and ***P < 0.001.Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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Sensitivity of cytokine detection using flow cytometry Figure 6
Sensitivity of cytokine detection using flow cytometry. Histograms and dot plots of IL-1β (A) and TNF-α (B) expres-
sion in LPS-activated peritoneal macrophages versus macrophages/granulocytes isolated from cortex 24 hours after pMCAO. 
Light colored histograms represent cells stained with isotype control antibodies and filled histograms represent cells stained 
with antibodies for either IL-1β (A) or TNF-α (B).Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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IL-1β and TNF-α are expressed by macrophages and microglia Figure 7
IL-1β and TNF-α are expressed by macrophages and microglia. (A) Infiltrating GFP+ cells consist of Gr1+ granulocytes 
and Gr1- macrophages. (B) Double immunofluorescence for Gr1+ granulocytes and either IL-1β or TNF-α showed no detecta-
ble co-expression 24 hours after pMCAO. Immunofluorescence detection of GFP and IL-1β (C) or TNF-α (D) showed that  
these cytokines are expressed by resident GFP- microglia and infiltrating GFP+ macrophages (E) Immunofluorescence double 
staining confirmed the flow cytometry results by showing that IL-1β and TNF-α are expressed by largely segregated subpopu-
lations of cells. Very few IL-1β+TNF-α+ co-expressing cells were identified during microscopic analysis (E). Gr1+ granulocytes 
were visualized using Alexa Fluor® 594-conjugated goat anti-rat IgG, and IL-1β+ and TNF-α+ cells using both Alexa Fluor® 488-
conjugated goat anti-rabbit and chicken anti-rabbit IgG. Scale bars: 50 μm (A) 20 μm (insert, A), 20 μm (B-E).Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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to observe a reduction in the number of CD11b+CD45dim
microglia 12 and 24 hours after pMCAO. We wondered
whether determination of upregulation of CD45, which is
widely used to detect both resting and activated microglia
in flow cytometry [24,27-29,31] and histology [32,33],
might lead to increased detection. Indeed, MFI analysis
showed that CD45 levels are upregulated in microglia 12–
24 hours after pMCAO. However, microglial expression of
CD45 was far below that expressed by macrophages/gran-
ulocytes, confirming results by others [34]. Using a bone
marrow chimeric approach, we observed that approxi-
mately 7% of the CD45dim microglia were GFP+ after 24
hours of pMCAO, suggesting that BM-derived microglial
precursors could also contribute to the expansion of the
microglial population after ischemic stroke in non-chi-
meric mice. Infiltration of GFP+ cells was specific to the
infarcted cortex, since no increase was observed in the
contralateral hemisphere of BM-chimeric mice or in
unmanipulated BM-chimeric mice. Other factors contrib-
uting to the expansion of the microglial population 12
and 24 hours after pMCAO might be immigration of
microglia from regions of the brain not included in the
preparation used for flow cytometry, or microglial prolif-
eration. However, microglial proliferation is not promi-
nent at 12 and 24 hours, but is first evident at 48 and 72
hours after induction of focal cerebral ischemia [34], a
finding that is similar to observations in other models of
acute neural injury [32,36,37].
The use of a GFP BM-chimeric approach in our study of
pMCAO served two purposes: 1) direct visualization of
infiltrating GFP+ cells in tissue sections and 2) validation
of the BM origin of the CD11b+CD45high macrophages/
granulocytes identified by flow cytometry in our model.
In addition to the massive infiltration of GFP+ macro-
phages/granulocytes 24 hours after pMCAO, we found
that a small proportion of microglia in the infarcted cortex
could be classified as GFP+ CD11b+CD45dim microglial
cells. These observations confirm findings by others [38-
42], showing a lesion-induced recruitment of microglial
progenitors of bone marrow origin into the infarcted cor-
tex. Recently it has been suggested that these microglial
progenitors would not enter into the bloodstream or cross
the blood-brain barrier under normal physiological con-
ditions [43,44]. However, BM-derived cells have been
reported to infiltrate non-irradiated normal brain [45-47],
and CD45high leukocytes are routinely detected in unma-
nipulated, perfused brains by flow cytometry [24,27].
Although focal cerebral ischemia disrupts the blood brain
barrier [33,39], and irradiation in itself preconditions the
brain for cells to infiltrate the neuropil [43,44], we in line
with earlier findings [44] observed only sporadic GFP+
cells in contralateral, non-ischemic cortex and in the
brains of unmanipulated BM-chimeric mice. Further-
more, numbers of CD11b+CD45high macrophages/granu-
locytes recruited to ischemic cortex 24 hours after pMCAO
were not different between BM-chimeric mice and non-
irradiated mice. This suggests that any damage induced by
irradiation alone was insufficient to trigger excessive entry
of BM-derived cells into the CNS.
Our observation of a significant reduction in microglial
population in the cortex of unmanipulated BM-chimeric
mice compared to unmanipulated non-chimeric mice
indicates that irradiation might impair microglial turno-
ver in normal brain. This is supported by observations by
Wirenfeldt et al. [24], who reported that microglial num-
bers were reduced by approximately 30% in unmanipu-
lated contralateral hippocampi of perforant pathway-
lesioned BM-chimeric mice. That study also reported a
lesion-induced impairment of the mitotic capacity of
microglia in BM-chimeric mice [24]. Taken together, we
ascribe the reduced microglial numbers in BM-chimeric
mice to irradiation damage.
The quantification of BM-derived GFP+ cells was done by
use of an approximated stereological approach, and by
use of flow cytometry. The results show that approxi-
mately 2/3 of GFP+ cells are lost during tissue processing
procedures prior to flow cytometric analysis. Since GFP+
cells located in perivascular aggregates were not included
in the approximated stereological analysis, cell loss using
flow cytometry might be larger than 2/3. However, the
consistency in the data shows that flow cytometry is a reli-
able and robust tool with which to obtain quantitative
data on microglia and infiltrating macrophages/granulo-
cytes in brain pathology, as also has been shown in previ-
ous studies [24,27]. Observations made by others using
BM-chimeric mice have shown that BM cells have the
capacity to differentiate into microglia and perivascular
cells [24,39,48], as well as non-myeloid cell types such as
endothelial cells, pericytes, astrocytes and neurons
[38,42,47,49]. However, in our study of mice with 24-
hour survival after pMCAO, we observed no evidence of
co-expression of GFP with the astroglial marker GFAP,
confirming earlier studies [38,49]. Similarly, we find no
clear evidence of co-expression of GFP and vWF/CD31,
although such co-expression has been previously reported
at later times of observation (3 days – 1 month) after
induction of ischemia [38,50].
Conclusion
We show that IL-1β and TNF-α are produced by largely
non-overlapping subsets of microglia and macrophages
after pMCAO in mice. This observation is indicative of
activation of distinct signalling pathways in different sub-
populations of microglia and macrophages after ischemic
stroke. Resolution of these pathways may further the
development of cytokine-based therapies in stroke.Journal of Neuroinflammation 2008, 5:46 http://www.jneuroinflammation.com/content/5/1/46
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